FGH-10019
CAS No. 1046045-61-7
FGH-10019 ( —— )
Catalog No. M21072 CAS No. 1046045-61-7
FGH-10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 244 | Get Quote |
|
10MG | 354 | Get Quote |
|
25MG | 592 | Get Quote |
|
50MG | 843 | Get Quote |
|
100MG | 1143 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFGH-10019
-
NoteResearch use only not for human use.
-
Brief DescriptionFGH-10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).
-
DescriptionFGH-10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSREBPs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1046045-61-7
-
Formula Weight373.49
-
Molecular FormulaC18H19N3O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:38 mg/mL (101.74 mM)
-
SMILESCCCc1cc(-c2nc(-c3ccc(NS(C)(=O)=O)cc3)cs2)ccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kamisuki S Shirakawa T Kugimiya A et al. Synthesis and Evaluation of Diarylthiazole Derivatives That Inhibit Activation of Sterol Regulatory Element-Binding Proteins[J]. Journal of Medicinal Chemistry 2011 54(13):4923-4927.
molnova catalog
related products
-
Licarbazepine
Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
-
Monocrotaline N-Oxid...
Monocrotaline N-Oxide is a monocrotaline metabolite.
-
Heneicosanoic acid
Heneicosanoic acid (HEA) is a fatty acid found in human milk fat. HEA is also a part of the phospholipids of the articular cartilage boundary lubricant. HEA is a constituent of red blood cell fatty acids.